Physician profile
Robert M Molloy
NPI 1104840933
$2,254,789.79
in general payments reported to CMS, 2019-2025
8 companies · $799K in 2025
The $799K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186K · 2020: $61K · 2021: $135K · 2022: $196K · 2023: $135K · 2024: $742K · 2025: $799K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.2M · Consulting Fee: $350K · Travel and Lodging: $69K · Food and Beverage: $9,313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,247,829.67 |
| Consulting Fee | $350,125.00 |
| Travel and Lodging | $68,703.72 |
| Food and Beverage | $9,313.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,253,200.21 | 2019-2025 | Insignia, Triathlon, Restoration |
| Zimmer Biomet Holdings, INC. | $825.23 | 2019-2025 | Rosa, Persona |
| Bone Support INC. | $209.06 | 2022 | |
| Think Surgical, INC. | $143.05 | 2023 | |
| Biocomposites INC | $134.67 | 2023 | Stimulan |
| Onkos Surgical, INC. | $122.49 | 2025 | Eleos Limb Salvage System |
| Smith+Nephew, INC. | $88.83 | 2022 | |
| Depuy Synthes Sales INC. | $66.25 | 2022-2023 | Na, Va-Lcp |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Molloy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.